Kite and Refuge Biotechnologies join to develop potential treatments for blood cancer

Retrieved on: 2022-10-21 11:56:16

Tags for this article:

Click the tags to see associated articles and topics

Kite and Refuge Biotechnologies join to develop potential treatments for blood cancer. View article details on hiswai:

Excerpt

Kite – a Gilead Company – has entered into an exclusive, worldwide licence agreement with Refuge Biotechnologies (Refuge), a synthetic biology ...

Article found on: www.pmlive.com